Skip to main content
. 2022 Jan 10;11:688679. doi: 10.3389/fonc.2021.688679

Table 2.

Baseline clinical characteristics comparison of patients between immunotherapy training set and chemotherapy cohorts.

Variables Sample Immunotherapy Chemotherapy P Value
Age, median 62 (56, 68) 60 (55, 65) 0.165
Sex, No. (%) 0.769
 Male 102 76 (83.52%) 26 (81.25%)
 Female 21 15 (16.48%) 6 (18.75%)
Smoking history, No. (%) 0.157
 Non-smokers 35 29 (31.87%) 6 (18.75%)
 Smokers 88 62 (68.13%) 26 (81.25%)
Pathological type, No. (%) 0.016
 Adenocarcinoma 70 46 (50.55%) 24 (75.00%)
 Others 53 45 (49.45%) 8 (25.00%)
Distant metastasis, No. (%) 0.8
 Absence 25 18 (19.78%) 7 (21.88%)
 Presence 98 73 (80.22%) 25 (78.12%)